This profile has not been claimed and data may not be accurate.
9th percentile
91st percentile
NFL MVP quarterback turned GP co-founding consumer growth equity firm Rx3
Credibility
Firm Standing · 72th percentile
- Active GP and co-founder of Rx3 Ventures, a consumer-focused growth equity fund.
- Partner and General Partner at Rx3 Growth Partners, a recognized consumer growth equity firm.
Relationship Matrix
Founder score
- 95%Probability of being accurate (95%)Current co-founder and General Partner of Rx3 Growth Partners, a consumer-focused growth equity firm.
Investor score
- 95%Probability of being accurate (95%)Active GP and co-founder of Rx3 Ventures, a consumer-focused growth equity fund.
- 92%Probability of being accurate (92%)Partner and General Partner at Rx3 Growth Partners, a recognized consumer growth equity firm.
- 90%Probability of being accurate (90%)Publicly identified as an angel investor and venture capitalist across multiple outlets.
- 88%Probability of being accurate (88%)Invested in VICIS, Hims, CorePower Yoga, Hydrow, and Amberjack as confirmed portfolio companies.
- 85%Probability of being accurate (85%)Rx3 Ventures was founded in 2018, giving approximately 6 years of investing experience.
- 65%Probability of being accurate (65%)Portfolio company Manscaped reached unicorn status with a $1B valuation.
- 55%Probability of being accurate (55%)Portfolio company CorePower Yoga was acquired by TSG Partners for several hundred million dollars.
What you likely need
You need events that help you shed the 'athlete-investor' label and establish Rx3 as a serious institutional-grade consumer VC platform. The highest-leverage gatherings will put you in rooms with endowment and family office allocators who evaluate GPs on track record and thesis rigor, not celebrity networks. You'll also benefit from operator-heavy dinners where you can deepen value-add relationships that differentiate Rx3 beyond endorsement capital.
Would you attend these IRL Festival events?
We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.
- fundraisingA closed-door dinner with endowment and university foundation allocators (MIT, Stanford, Duke investment offices) actively building emerging manager VC allocations, where Rx3 can present Fund I exits including CorePower and the Manscaped unicorn milestone as a verified consumer track record
- positioningA GP roundtable with consumer-focused fund managers (Forerunner, Coefficient Capital, Imaginary Ventures) to pressure-test Rx3's Fund III thesis and get candid feedback on how institutional co-investors evaluate athlete-backed platforms
- fundraisingA family office LP happy hour targeting single-family offices with consumer brand heritage (Walton Enterprises, Pritzker Group) who understand retail and lifestyle investing and can anchor Rx3's Fund III with institutional credibility
- introsA dinner with senior operators from DTC and retail distribution networks (Ulta, Target's emerging brands team, Shopify Plus merchants) to build Rx3's value-add bench beyond celebrity endorsement for current and future portfolio companies
- positioningA working session with emerging GPs who have published notable LP annual letters (Bedrock's Geoff Lewis, Slow's Jared Heyman) to workshop the structure and positioning of Rx3's first public consumer-brand investment thesis letter
- positioningA roundtable with investors who have successfully transitioned from celebrity or athlete identity to recognized full-time GP status (Magic Johnson Enterprises, Kevin Durant's Thirty Five Ventures) to map the deliberate rebranding moves that shifted LP and co-investor perception
- tacticalA tactical office hours session with PitchBook and Crunchbase relationship managers alongside other emerging fund GPs to audit and fully rebuild Rx3's fund and portfolio data profiles for maximum co-investor discoverability ahead of Fund III launch
- introsA dinner with M&A advisors and strategic acquirers active in consumer wellness and lifestyle (L Catterton dealmakers, Unilever Ventures, Foot Locker Ventures) to surface exit pathway conversations for Rx3's current Fund I and II portfolio companies and build a documented returns narrative
